Home / Intelligence / Case Studies / Strategic Recommendations About Potential Actions to Shape Bone Health Policy
Trinity completed a detailed analogue assessment to understand how various stakeholders are involved in shaping health policies across markets.
Geographic Scope:

Client Situation
The client wanted to identify best practices as well as the external stakeholders they should consider working with to efficiently shape global bone health policy.
Trinity’s Solution
Trinity conducted a systematic analogue disease area filtration to understand the disease areas where health policy development is most comparable to the bone health space.
Trinity then conducted exhaustive secondary research within each analogue disease area to understand the most relevant health policy shaping stakeholders, their actions, and consequent impact; leverage key learnings from each analogue disease area to inform bone health policy recommendations.
Deliverables
- Analogue selection and methodology
- High level executive summary explaining overall trends
- Analogue assessments for five disease areas of interest
- Recommendations for exploring partnerships in developing bone health policy
Project Outcomes & Impact
The client was able to understand the strategic actions they could take in order to shape bone health policy across several markets and define the success factors that drive stakeholder engagement in policy-shaping activities. The client was also able to develop compelling case studies in order to gather cross-functional buy-in.
Related Intelligence
Webinars
Elevating Commercialization in China Part 2: The Key to Pricing and Access Optimization
Available On Demand
In Part 1 of this webinar series, The Path to Launch, we discussed various pathways and innovative programs to accelerate product launch in China. However, launching a product is only half of the battle. Ensuring optimal access to deliver the treatment to more patients is also critical for commercial success. Join Trinity Life Sciences’ APAC experts […]
Watch Now
Blog
The Implementation Game: The Inflation Reduction Act Medicare Drug Price Negotiation Program Guidance
Trinity’s Take Introduction Since the Inflation Reduction Act (IRA) was signed into law in August 2022, biopharma stakeholders have noted the high likelihood of the legislation being challenged in court alongside many questions about how some of the new CMS programs would function. The Medicare Drug Price Negotiation Program is one IRA program expected to […]
Read More
Blog
The Future of AI for Market Access: An ISPOR US 2023 Recap
This year Trinity team members at ISPOR 2023 attended several symposia and presentations on the use of Artificial Intelligence (AI) to support biopharma evidence generation. Among many industry trends, experts anticipate that AI and machine learning will increasingly be leveraged to identify optimal patient populations and expedite the path toward personalized medicine. Pioneering New Frontiers […]
Read More